Table 2.
Patients demographics
| All patients | AF | No AF | p value, OR (95% CI) | |
|---|---|---|---|---|
| Male, n | 73 (54.9%) | 7 (23.3%) | 66 (64.1%) | <0.001, OR 0.17 (95% CI 0.06–0.439 |
| Age (years), mean ± SD | 63.1±15 | 71.3±10 | 60±15 | p=0.001 |
| Age >62 year, n | 73 | 24 | 49 | p=0.002 OR 4.4 (95% CI 1.6–11.6) |
| Hypertension, n | 83 (62.4%) | 22 (73.3%) | 61 (59.2%) | p=0.16 OR 1.8 (95% CI 0.77–4.6) |
| DM, n | 51 (38.3%) | 11 (36.7%) | 40 (38.8%) | p=0.83 OR 0.91 (95% CI 0.39–2.16) |
| CAD, n | 22 (16.5%) | 2 (6.7%) | 20 (19.4) | p=0.16 OR 0.29 (95% CI 0.06–1.34) |
| Previous stroke/TIA, n | 33 (24.8%) | 6 (20%) | 27 (26.2%) | p=0.48 OR 0.70 (95% CI 0.26–1.90) |
| PAD, n | 1 (0.8%) 0 | 0 | 1 (1%) | p=1 |
| Hyperlipidemia, n | 49 (36.8%) | 10 (33.3%) | 39 (37.9%) | p=0.65 OR 0.82 (95% CI 0.34–1.93) |
| Smoking, n | 21 (15.8%) | 0 | 21 (20.4%) | p=0.004 |
| NIHSS baseline | 4 (IQR3–7) 5.1±3.1 |
4.5 (IQR3–8.25) 5.7±3.6 |
4 (IQR3–7) 4.9±2.9 |
p=0.35 |
| NIHSS ≥8, n | 26 | 8 | 18 | p=0.264 |
| mRs | 1 (IQR1–2) | 1 (IQR1–2) | 1 (IQR1–2) | p=0.48 |
| Mitral insufficiency, n | 73 (% 54.9) | 22 (73.3%) | 51 (49.5%) | p=0.023 OR 2.8 (95% CI 1.14–6.87) |
| Mitral stenosis, n | 1 (0.8%) | 0 | 1 (1%) | p=1 |
| Aortic insufficiency, n | 30 (23.3%) | 12 (40%) | 18 (18.4%) | p=0.014 OR 2.9 (95% CI 1.21–7.13) |
| Aortic stenosis, n | 1 (0.8%) | 0 | 1 (1%) | p=1 |
| LVH, n | 83 (62.4%) | 21 (70%) | 62 (60.2%) | p=0.32 OR 1.54 (95% CI 0.64–3.70) |
| Left ventricular systolic dysfunction, n | 13 (9.8%) | 0 | 13 (12.6%) | |
| Left atrial dilatation, n | 49 (36.8%) | 16 (53.3%) | 33 (32%) | p=0.033 OR 2.4 (95% CI 1.05–5.54) |
AF, atrial fibrillation; DM, diabetes mellitus; CAD, coronary artery disease; NIHSS, National Institute of Stroke Scale; LVH, left ventricular hypertrophy; PAD, peripheral artery disease; mRs, modified Rankin scale; NIHSS, National Institutes of Health Stroke Scale.